CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
about
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentThe Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinomaCD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-AnalysisCD147 immunoglobulin superfamily receptor function and role in pathologyIncreased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancerMicrovessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysisA novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells.Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer.Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells.CD147 expression was positively linked to aggressiveness and worse prognosis of gastric cancer: a meta and bioinformatics analysis.Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma.HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.A protein chip approach for high-throughput antigen identification and characterization.Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages.New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
P2860
Q26771312-058BE3CA-056D-42BF-8D75-A08E0E34BC3CQ26851211-1ED2663C-D703-4904-A25C-5D7328EAFC44Q27300764-A7A365C7-E842-4701-B1BA-1B3591CA47B6Q33843943-CB170B10-160B-4C0C-9C3E-81DE8C2FD86FQ33974601-16C19039-D50F-47DC-9AED-3DE95442F348Q34582041-76C717BD-609C-4A69-96D9-5DC88F0B9B57Q35014219-AF498759-23BF-450D-A643-5E49535FAA82Q36339219-299ACBFE-DA41-41D6-8AE6-C2FC6EA0DFB5Q36398938-1F608018-CD3D-4A95-BA95-F950F161A3F8Q36420282-5D1F9349-0F0D-47E7-813E-BFCDA9AB2C25Q36767255-6E7A074D-FE64-41C6-B8F5-C013A0352163Q37281023-39F33649-6E41-4B30-B5A7-CB900F885875Q37338042-A4504E9A-4908-4983-8610-4424AFF8CFBDQ37463744-21207265-074A-4843-A37D-ED5091397B47Q37584674-604FBB61-B5DE-4CAF-A209-00E2FB3CA67CQ37589853-AE3F9FDF-B825-435D-B033-A8B53AE43E81Q38765991-6974F8C4-6F24-4ACD-9559-50A50F6F263EQ38983451-B7E1AEB5-C52E-41CC-8855-1FF22D452B73Q39197756-58A11C9A-2292-40C7-AAD3-A23F8AA6EB30Q39748993-26E29B8C-7CCB-4065-86BD-BCA5C7B3BCDEQ40602159-C51D7745-B5C6-41D4-A5B1-9C4A2CC70B10Q42364473-C45A5549-817B-4352-9BBD-5BBA9554F41CQ43137955-08B5A2DB-E5AC-4BDB-98CA-B70FD608A196Q44479261-4678FD46-B4B6-4EB5-8E30-62C00EAAA0BBQ45342027-92B5D2A6-856D-4985-BF14-1915DD0C7D3CQ47119971-66C10FF7-032A-47F6-86E3-A6F9140CA3EFQ47738876-3EEE6E54-EC23-412E-B539-DEACB52474A0Q47811362-02E6C5FD-0BB1-4554-A40C-92265BEC7B04Q48669602-2BB762E5-6DA6-4707-B5DF-1CE267764FB6Q51080130-3215B0E9-17A5-4D23-9CEF-36A9214BB331Q51579727-90122126-DD33-4B07-84FB-0F902DD3386AQ53059665-BBE92EC2-2938-4C94-A254-16872DAD99A8Q53325341-CEA84E9F-0815-4B1B-9A6D-45A1AEAAD808Q55518185-5E6F1FD6-E3A6-47F5-AE35-EF2F389B1C24Q57482211-944052EF-13B3-492D-8EA5-1C611141DABD
P2860
CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@en
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@nl
type
label
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@en
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@nl
prefLabel
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@en
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@nl
P2093
P356
P1476
CD147, MMP-2, MMP-9 and MVD-CD ...... tocellular carcinoma patients.
@en
P2093
Guangsheng Chen
Qing Zhang
Qingchuan Zhao
Xinguo Chen
Zhinan Chen
P304
P356
10.4161/CBT.5.7.2754
P577
2006-07-30T00:00:00Z